Aptevo Therapeutics logo
Aptevo Therapeutics APVO
$ 6.91 3.75%

Quarterly report 2025-Q3
added 11-06-2025

report update icon

Aptevo Therapeutics Cash Conversion Cycle 2011-2026 | APVO

Annual Cash Conversion Cycle Aptevo Therapeutics

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - -47.4 -239 128 143 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
143 -239 -3.81

Quarterly Cash Conversion Cycle Aptevo Therapeutics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - - - - - - - - - - - - - - - - -32.4 -6.99 -125 - -69.9 -286 -144 - 31.6 18.1 52.1 3.19 74.4 38.4 60.7 71.1 89.8 41.5 - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
89.8 -286 -11.5

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
AbCellera Biologics AbCellera Biologics
ABCL
173 $ 3.64 -1.89 % $ 1.09 B canadaCanada
ADMA Biologics ADMA Biologics
ADMA
355 $ 16.45 0.43 % $ 3.92 B usaUSA
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
235 $ 76.75 0.85 % $ 1.48 B usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
115 $ 19.93 -1.14 % $ 2.51 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-2.85 K - -11.43 % $ 502 K usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
-400 $ 0.83 4.23 % $ 4.53 M chinaChina
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
-123 - - $ 521 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
340 - -4.8 % $ 255 M usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
-256 $ 163.82 -0.14 % $ 8.15 B usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
-114 $ 66.98 3.8 % $ 12.8 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Avid Bioservices Avid Bioservices
CDMO
85.5 - - $ 789 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
164 - -16.75 % $ 25.8 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Clovis Oncology Clovis Oncology
CLVS
65.5 - -7.23 % $ 13 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
117 - -24.86 % $ 820 K usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
733 $ 60.75 3.79 % $ 11.7 B usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
-216 - - $ 1.2 B usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
-1.6 K - -5.98 % $ 34.1 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-1.6 K - -4.36 % $ 27 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
-101 - - $ 2.18 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
-8.96 K - -10.17 % $ 12.2 K usaUSA
Codexis Codexis
CDXS
-48.2 $ 1.1 12.24 % $ 80.7 M usaUSA
Certara Certara
CERT
81.8 $ 7.33 1.24 % $ 1.18 B usaUSA
Evofem Biosciences Evofem Biosciences
EVFM
-630 - 7.55 % $ 38.1 M usaUSA